This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Thermo Fisher Scientific Inc (TMO)

NYSE: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 1.27B 1.18B 1.02B 1.04B
Operating Gains/Losses 0.00 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -147.90M 12.00M -107.30M -89.50M
(Increase) Decrease in Inventories -72.20M -59.90M -32.50M -27.90M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 -81.30M
(Decrease) Increase In Payables 47.00M 10.00M 31.40M 2.50M
(Decrease) Increase In Other Current Liabilities 163.30M 127.20M 0.00 0.00
(Increase) Decrease In Other Working Capital 130.50M -123.60M -156.50M 9.30M
Other Non-Cash Items 94.50M 242.20M 183.30M 161.40M
Net Cash From Continuing Operations 2.02B 2.07B 1.68B 1.51B
Net Cash From Discontinued Operations -4.90M -28.40M 12.60M -700.00K
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 2.01B 2.04B 1.69B 1.51B
Sale of Property, Plant & Equipment 20.70M 12.80M 8.20M 10.20M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -282.40M -315.10M -266.50M -265.50M
Acquisitions -11.40M -1.08B -5.68B -606.20M
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 2.20M -800.00K -6.00M -1.50M
Cash Provided by Financing Activities
Net Cash From Investing Activities -263.30M -1.33B -5.14B -858.90M
Issuance of Debt 0.00 1.28B 4.25B 741.40M
Cash Used for Financing Activities
Issuance of Capital Stock 0.00 254.10M 158.10M 77.30M
Repayment of Long-Term Debt -1.00M -354.50M -453.40M -1.11B
Repurchase of Capital Stock -89.80M -1.15B -1.34B -1.01B
Payment of Cash Dividends -216.20M -142.20M 0.00 0.00
Other Financing Charges, Net 3.62B -807.20M 929.30M 12.80M
Net Cash From Financing Activities 3.31B -917.70M 3.55B -1.30B
Effect of Exchange Rate Changes -37.00M 38.70M -200.00K 0.00
Net Change in Cash & Cash Equivalents 5.02B -165.30M 99.20M -647.00M
TMO News

TMO Thermo Fisher Scientific Inc

Analysts Ratings for TMO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 11 11 12 12
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET TMO ANALYST REPORT

Brokerage Partners

TMO Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs